Jubilant Ingrevia Moat Analysis: Score & Risks
Jubilant Ingrevia Ltd.
A first-pass moat teardown of Jubilant Ingrevia Ltd., built from single-pass filing evidence. Free note — provisional, and the full two-pass deep dive may revise it.
First-pass narrow read — primary edge in Cost Advantage. Provisional, single-pass evidence.
Jubilant Ingrevia Ltd. scores 5.24 on MoatSCORE 6.0 — a narrow moat in Chemicals. This is a first-pass note: the dimensional read and the filing receipts below come from a single GFIP evidence pass, not the full two-pass deep corpus behind our flagship deep dives. Provisional — published free while the deep version is queued.
Seven dimensions of moat
Ordered by contribution. Each dimension carries a verified filing quote, graded [M] mechanism or [O] outcome.
“By driving plant performance through superior utilisation, we enhance fixed-cost absorption, improve profitability, and set the stage for accelerated volume growth.”
“Speciality Chemicals revenue grew by 24% YoY driven by volume and price growth across products.”
“Through the contract, we will supply two key GMP intermediates for one 'patented drug' of the innovator pharmaceutical customer.”
“Our 7,000 TPA capacity, which was commissioned towards the close of FY 2022, fills-in this gap.”
“China, of course, at least in agrochemicals from whatever we understand, has created a lot of capacity, and we still think there is excess capacity there.”
“launching Remdesivir under 'JUBI-R' and making it available to over 1,000 hospitals providing COVID-19 treatment in India through its distribution network”
D8 rating: ADEQUATE. Not part of the moat score — it governs the cost of equity and the fade window. First-pass; not yet deep-reviewed.
The barrier gate — first-pass
Effective barrier 6 — at or above 6, consistent with a narrow read. First-pass estimate.
Deep two-pass review. This draft rests on a single GFIP evidence pass; the full 10-year AR + concall corpus may move the read.
The barrier gate. A firmer replication or bypass estimate is the most likely thing to shift the band.
Adverse events. Any governance, regulatory or funding shock captured in D8 could re-rate the fade window.
Where this note fits. This company is one of 509 Indian companies we have scored for moat durability — 370 narrow, 126 narrow-trending-wide, none wide. Every score, dimension by dimension, is free in the Moat Screener.
Member discussion